Brian Joseph Pepe-Mooney, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Diseases | 1 | 2023 | 1253 | 0.510 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2019 | 2916 | 0.480 |
Why?
|
| Hepatocytes | 2 | 2019 | 1211 | 0.440 |
Why?
|
| Porphyrins | 2 | 2011 | 348 | 0.420 |
Why?
|
| Peptides | 3 | 2011 | 4409 | 0.350 |
Why?
|
| Cell Cycle Proteins | 3 | 2019 | 3462 | 0.330 |
Why?
|
| Epithelial Cells | 1 | 2019 | 3690 | 0.290 |
Why?
|
| Biocompatible Materials | 2 | 2012 | 1736 | 0.290 |
Why?
|
| Liver | 2 | 2019 | 7474 | 0.270 |
Why?
|
| Tissue Scaffolds | 1 | 2012 | 956 | 0.260 |
Why?
|
| Multiprotein Complexes | 1 | 2011 | 1119 | 0.260 |
Why?
|
| Colitis, Ischemic | 1 | 2021 | 31 | 0.200 |
Why?
|
| Enterocolitis | 1 | 2021 | 102 | 0.180 |
Why?
|
| Surface Properties | 3 | 2012 | 1184 | 0.180 |
Why?
|
| Phosphoproteins | 3 | 2018 | 2440 | 0.170 |
Why?
|
| Ribosomes | 1 | 2021 | 500 | 0.160 |
Why?
|
| Liver Regeneration | 1 | 2019 | 210 | 0.150 |
Why?
|
| Ubiquitin | 1 | 2022 | 852 | 0.150 |
Why?
|
| Microscopy, Atomic Force | 3 | 2012 | 250 | 0.140 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 1338 | 0.140 |
Why?
|
| Embryo, Mammalian | 1 | 2022 | 1701 | 0.140 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2022 | 3386 | 0.130 |
Why?
|
| Mediator Complex | 1 | 2015 | 109 | 0.130 |
Why?
|
| Circular Dichroism | 2 | 2011 | 354 | 0.120 |
Why?
|
| Neuroblastoma | 1 | 2021 | 1226 | 0.120 |
Why?
|
| Cell Dedifferentiation | 1 | 2014 | 135 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 8428 | 0.110 |
Why?
|
| Cell Lineage | 1 | 2022 | 2504 | 0.110 |
Why?
|
| Hematopoiesis | 1 | 2022 | 2072 | 0.110 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 1903 | 0.110 |
Why?
|
| Citric Acid | 1 | 2012 | 126 | 0.100 |
Why?
|
| Durapatite | 1 | 2012 | 161 | 0.100 |
Why?
|
| Chitosan | 1 | 2012 | 141 | 0.100 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 4851 | 0.100 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2012 | 319 | 0.090 |
Why?
|
| Bile Duct Neoplasms | 1 | 2015 | 567 | 0.090 |
Why?
|
| Cholangiocarcinoma | 1 | 2015 | 516 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2012 | 2557 | 0.090 |
Why?
|
| Spectrum Analysis | 1 | 2011 | 454 | 0.090 |
Why?
|
| Photochemical Processes | 1 | 2009 | 84 | 0.090 |
Why?
|
| Adsorption | 1 | 2009 | 201 | 0.080 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2012 | 302 | 0.080 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 2183 | 0.080 |
Why?
|
| Electricity | 1 | 2009 | 182 | 0.080 |
Why?
|
| Protein Structure, Secondary | 1 | 2011 | 1246 | 0.080 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2012 | 687 | 0.080 |
Why?
|
| Homeostasis | 1 | 2019 | 3340 | 0.080 |
Why?
|
| Pyridines | 1 | 2019 | 2825 | 0.070 |
Why?
|
| Cell Line, Tumor | 4 | 2021 | 16689 | 0.070 |
Why?
|
| Signal Transduction | 4 | 2019 | 23403 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2019 | 10481 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2018 | 2214 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2012 | 3144 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2915 | 0.060 |
Why?
|
| Models, Molecular | 2 | 2011 | 5456 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2019 | 14557 | 0.060 |
Why?
|
| Nanotechnology | 1 | 2009 | 710 | 0.060 |
Why?
|
| Pandemics | 1 | 2023 | 8388 | 0.060 |
Why?
|
| Aging | 1 | 2022 | 8664 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 4253 | 0.050 |
Why?
|
| Mice | 5 | 2022 | 81183 | 0.050 |
Why?
|
| Multipotent Stem Cells | 1 | 2022 | 186 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 21827 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18029 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2012 | 3479 | 0.040 |
Why?
|
| Benzodiazepinones | 1 | 2018 | 51 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 3557 | 0.040 |
Why?
|
| Animals | 6 | 2022 | 168757 | 0.040 |
Why?
|
| Cell Line | 1 | 2012 | 15997 | 0.040 |
Why?
|
| Myosins | 1 | 2018 | 409 | 0.040 |
Why?
|
| Ethanol | 1 | 2022 | 1342 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2018 | 479 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2015 | 66 | 0.030 |
Why?
|
| DNA Polymerase II | 1 | 2015 | 107 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2012 | 11483 | 0.030 |
Why?
|
| Humans | 7 | 2023 | 744343 | 0.030 |
Why?
|
| Flavonoids | 1 | 2015 | 443 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2018 | 3689 | 0.030 |
Why?
|
| Zebrafish | 1 | 2022 | 2994 | 0.020 |
Why?
|
| Actins | 1 | 2018 | 2121 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2014 | 739 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2009 | 220 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2015 | 1341 | 0.020 |
Why?
|
| Piperidines | 1 | 2015 | 1602 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2009 | 689 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2015 | 2924 | 0.020 |
Why?
|
| Male | 2 | 2021 | 350118 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2009 | 2839 | 0.020 |
Why?
|
| Female | 2 | 2021 | 380194 | 0.010 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 13695 | 0.010 |
Why?
|
| Chromatin | 1 | 2015 | 2934 | 0.010 |
Why?
|
| Protein Binding | 1 | 2015 | 9386 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 9734 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 2699 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 7722 | 0.010 |
Why?
|
| Stem Cells | 1 | 2014 | 3567 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 13815 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 18111 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2015 | 12208 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 163280 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 213383 | 0.000 |
Why?
|
| Adult | 1 | 2021 | 214055 | 0.000 |
Why?
|